We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-12.43%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$73.9B
AUM Growth
-$12.4B
(-14%)
Cap. Flow
-$7.83B
Cap. Flow
% of AUM
-10.58%
Top 10 Holdings %
Top 10 Hldgs %
21.74%
Holding
2,664
New
311
Increased
910
Reduced
656
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norfolk Southern
NSC
|
+$788M |
| 2 |
Union Pacific
UNP
|
+$641M |
| 3 |
Icon
ICLR
|
+$463M |
| 4 |
Wells Fargo
WFC
|
+$310M |
| 5 |
CSX Corp
CSX
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$599M |
| 2 |
Intercontinental Exchange
ICE
|
+$280M |
| 3 |
PepsiCo
PEP
|
+$246M |
| 4 |
FedEx
FDX
|
+$242M |
| 5 |
Colgate-Palmolive
CL
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.51% |
| 2 | Healthcare | 14.98% |
| 3 | Financials | 13.27% |
| 4 | Industrials | 10.94% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Biogen
BIIB
$30.5B
| $271K | ﹤0.01% |
1,334
+532
| +66% | +$109K |
|
1002
Chemours
CC
$2.19B
| $267K | ﹤0.01% |
8,369
+6,408
| +327% | +$236K |
|
1003
Halozyme
HALO
$9.91B
| $264K | ﹤0.01% |
6,003
+5,810
| +3,010% | +$251K |
|
1004
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
| $264K | ﹤0.01% |
2,600
| – | – |
|
1005
Insmed
INSM
$21.5B
| $255K | ﹤0.01% |
12,968
-9,817
| -43% | -$206K |
|
1006
Pool Corp
POOL
$7.51B
| $254K | ﹤0.01% |
727
-4,684
| -87% | -$1.86M |
|
1007
Radiant Logistics
RLGT
$392M
| $249K | ﹤0.01% |
33,578
+19,727
| +142% | +$127K |
|
1008
Quest Diagnostics
DGX
$26B
| $248K | ﹤0.01% |
1,868
-256
| -12% | -$34.9K |
|
1009
Resources Connection
RGP
$153M
| $248K | ﹤0.01% |
12,191
+4,919
| +68% | +$87.8K |
|
1010
Employers Holdings
EIG
$912M
| $246K | ﹤0.01% |
5,881
| – | – |
|
1011
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
| – | – |
0
| – | – |
|
|
SYNH
1012
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $242K | ﹤0.01% |
3,382
+2,717
| +409% | +$199K |
|
1013
MediaAlpha
MAX
$755M
| $241K | ﹤0.01% |
24,514
-206,887
| -89% | -$2.52M |
|
1014
Regenxbio
RGNX
$672M
| $240K | ﹤0.01% |
9,746
+3,158
| +48% | +$78.9K |
|
1015
Telefônica Brasil
VIV
$19.5B
| $240K | ﹤0.01% |
26,591
-25,774
| -49% | -$265K |
|
1016
TransDigm Group
TDG
$70.2B
| $237K | ﹤0.01% |
444
+409
| +1,169% | +$241K |
|
1017
Willis Towers Watson
WTW
$31.4B
| $235K | ﹤0.01% |
1,195
-14
| -1% | -$3K |
|
|
BGB
1018
Blackstone Strategic Credit 2027 Term Fund
BGB
$502M
| – | – |
0
| – | – |
|
1019
Exelixis
EXEL
$14.3B
| $233K | ﹤0.01% |
11,220
-418,079
| -97% | -$8.62M |
|
1020
Tenable Holdings
TENB
$3.97B
| $233K | ﹤0.01% |
5,152
-10,567
| -67% | -$544K |
|
1021
Box
BOX
$4.43B
| $232K | ﹤0.01% |
9,242
+8,431
| +1,040% | +$236K |
|
1022
BridgeBio Pharma
BBIO
$16.1B
| $230K | ﹤0.01% |
25,422
-6,455
| -20% | -$54K |
|
|
CCRN
1023
DELISTED
Cross Country Healthcare
CCRN
| $230K | ﹤0.01% |
11,082
+4,574
| +70% | +$85.7K |
|
1024
Acuity Brands
AYI
$10.7B
| $229K | ﹤0.01% |
1,493
+1,001
| +203% | +$170K |
|
1025
The Ensign Group
ENSG
$10.4B
| $229K | ﹤0.01% |
+3,124
| New | +$249K |
|
Similar funds
QCM
Lazard Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Lazard Asset Management held 2,664 positions worth $73.9B, down 14% from $86.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lazard Asset Management withdrew a net $7.83B in Q2 2022, closing 240 positions and reducing 656 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Aspen Technology Inc worth $74.1M.
- Lazard Asset Management's largest Q2 2022 buy was Aspen Technology Inc: 403,325 shares worth $74.1M.
- Lazard Asset Management added most to Norfolk Southern in Q2 2022, an estimated $788M increase.
- Lazard Asset Management's biggest Q2 2022 reduction was Medtronic, cutting an estimated $599M.
- Lazard Asset Management fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $156M.
- Lazard Asset Management's ten largest holdings make up 22% of its $73.9B portfolio in Q2 2022.
- Lazard Asset Management opened 311 new positions and closed 240 in Q2 2022.
- Lazard Asset Management's portfolio value fell 14% quarter-over-quarter to $73.9B.
Based on Lazard Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.